AndreaBozzo/ceres-open-data-index huggingface dataset:
Compound 530106: 5,6-Dihydrothymine, TMS

Chemical compound data from PubChem database. IUPAC Name: trimethyl-[(5-methyl-2-trimethylsilyloxy-4,5-dihydropyrimidin-6-yl)oxy]silane. Molecular Formula: C11H24N2O2Si2. Molecular Weight: 272.49. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525832: N,N-Dimethyl-N'-(4-methoxyphenyl)-propionamidine

Chemical compound data from PubChem database. IUPAC Name: N'-(4-methoxyphenyl)-N,N-dimethylpropanimidamide. Molecular Formula: C12H18N2O. Molecular Weight: 206.28. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525687: p-Chlorobenzylidene-heptyl-amine

Chemical compound data from PubChem database. IUPAC Name: 1-(4-chlorophenyl)-N-heptylmethanimine. Molecular Formula: C14H20ClN. Molecular Weight: 237.77. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NSDUH 2022 Editing And Imputation Report

Learn about the editing and statistical imputation procedures that were applied to respondent data for the 2022 National Survey on Drug Use and Health (NSDUH). Logical editing resolves inconsistencies or ambiguous data based on a respondent’s answers to other questions in the survey. Statistical imputation uses mathematical techniques to assign values when they are missing in the data.Introductory Chapters:An introduction, including a discussion of changes from the 2021 to 2022 survey.A description of the procedures and general principles for editing the NSDUH data.A description of the general imputation procedures used in NSDUH.Remaining chapters are descriptions of the editing and imputation for the following types of variables:Front-end demographics.Back-end demographics.Substance use.Special drugs and substance use disorder.Additional substance use, including treatment and emerging issues.Substance use risk and protective factors.Physical and mental health.Roster variables.Income.Health insurance.Pair variables.
Compound 525171: Nonaeythylene glycol, monoallyl ether, acetate

Chemical compound data from PubChem database. IUPAC Name: 2-[2-[2-[2-[2-[2-[2-[2-(2-prop-2-enoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl acetate. Molecular Formula: C23H44O11. Molecular Weight: 496.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Impaired Driving Death Rate, by Age and Sex, 2012 & 2014, Region 6 - Dallas

Rate of deaths by age/gender (per 100,000 population) for people killed in crashes involving a driver with BAC =>0.08%, 2012, 2014. 2012 Source: Fatality Analysis Reporting System (FARS). 2014 Source: National Highway Traffic Administration's (NHTSA) Fatality Analysis Reporting System (FARS), 2014 Annual Report File. Note: Blank cells indicate data are suppressed. Fatality rates based on fewer than 20 deaths are suppressed.
Compound 525126: 1,3-Benzenedicarboxylic acid, dihexyl ester

Chemical compound data from PubChem database. IUPAC Name: dihexyl benzene-1,3-dicarboxylate. Molecular Formula: C20H30O4. Molecular Weight: 334.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527346: 16,20,24,28-Tetramethyl-hentriacontyl cyanide

Chemical compound data from PubChem database. IUPAC Name: 17,21,25,29-tetramethyltritriacontanenitrile. Molecular Formula: C37H73N. Molecular Weight: 532.0. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400805-T1: [Translated] FLUORESCENCE ILLUMINATION SYSTEM FOR AN IMAGING DEVICE

A fluorescence imaging assembly including an imaging apparatus having an enclosure wall defining a view port into a light-tight imaging compartment thereof. A specimen platform is positioned in the imaging compartment having a support surface facing toward the view port. An illumination assembly includes a light source and a frame disposed in the imaging compartment. The illumination assembly is positioned proximate to and substantially peripherally encircling the view port. A bundle of fiber optic strands extends into the imaging compartment wherein proximal ends of the strands are in optical communication with the light source and distal ends thereof terminate at the frame to emit a conical directional beam of light onto the specimen platform. The distal ends of the fiber optic strands are sufficiently spaced peripherally about the view port such that the plurality of directional beams collectively illuminate the specimen platform in a substantially uniform manner.
Patent AT-E401813-T1: [Translated] BREWING TANK AND FOAM UNIT AND BEVERAGE MACHINE HAVING SUCH A BREWING TANK

A brewing receptacle for an apparatus for brewing a beverage such as coffee. The receptacle has a brewing chamber (13; 63; 113) having an entry passage and an exit passage for displacing water through the chamber (13; 63; 113) for brewing the beverage, a bottom (14; 64; 114) for supporting the particles (18; 118, 118′) (18), and a discharge 5 opening (19; 69; 119) in the bottom (14; 64; 114) for discharging beverage liquid through the bottom (14; 64; 114). At least the bottom (14; 64; 114) is invertible between a first and a second operative position. The brewing chamber (13; 63; 113) has a first volume and a first shape when the bottom (14; 64; 114) is in said first position and at least a second volume or a second shape of the brewing chamber in said second position is different from the first volume or shape, respectively.
Plasma colloid osmotic pressure in healthy infants

Background
          The plasma colloid osmotic pressure (COP) plays a major role in transcapillary fluid balance. There is no information on plasma COP of healthy infants beyond the first post-natal week. The normal COP in healthy adult subjects (25 mmHg) is currently also applied as a reference value for healthy infants. This study was designed to test whether plasma COP values in healthy infants are the same as those in normal adults.
        
        
          Methods
          Plasma COP was measured in 37 male and female healthy infants from 1 to 11 months old. For this purpose, 1 ml blood was collected during the patient's regularly scheduled visit if the patient required any type of blood test for routine laboratory analyses.
        
        
          Results
          Plasma COP levels correlated slightly with increasing age from 1 to 9 months old (linear regression analysis; r2 = 0.1, P < 0.049). We found no correlation between plasma COP and body weight at the same age (r2 = 0.05, P = 0.155). The mean and standard deviation of COP in all infants was 25.1 ± 2.6 mmHg, which is almost identical to an average COP of 25 mmHg in healthy adult subjects. Arbitrary division of the infants into three different age groups (1–3 months [n = 11], 5–8 months [n = 13] and 9–11 months [n = 13]) showed an average increase of approximately 2 mmHg in COP of 9-month-old to 11-month-old infants, compared with 1-month-old to 3-month-old infants (one-way analysis of variance; P = 0.26). There was no gender difference in the COP level (unpaired t-test), with an average of 25.1 ± 2.4 mmHg in 19 male infants compared with 25.2 ± 2.9 in 18 female infants. The 95% confidence interval for COP in both male and female infants (n = 37) was between 24.3 to 26.0 mmHg, ranging from 19.5 to 30.3 mmHg, with a median value of 25.2 mmHg.
        
        
          Conclusions
          The data accept the null hypothesis that the COP range in infants younger than 1 year old is similar to those observed in adult subjects. Our observations, compared with previously reported neonatal COP values, suggest that there is a sharp increase in COP within the first months after birth.
Erythromycin ethylsuccinate

Erythromycin Ethylsuccinate is an antibiotic used to treat bacterial infections. It's available as an oral suspension in strengths like 200 mg or 400 mg per 5 mL, packaged in 100 mL bottles. Manufactured by Cadila Pharmaceuticals Limited and Nivagen Pharmaceuticals, Inc., it's a prescription drug approved under ANDA216212. This information was generated using AI and is provided for informational and research purposes only.
NNDSS - Table II. Lyme disease to Meningococcal

NNDSS - Table II. Lyme disease to Meningococcal - 2014In this Table, all conditions with a 5-year average annual national total of more than or equals 1,000 cases but less than or equals 10,000 cases will be displayed (��� 1,000 and ��_ 10,000). The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.  Data on United States exclude counts from US territories. Note:These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. Footnotes:C.N.M.I.: Commonwealth of Northern Mariana Islands. U: Unavailable.    -: No reported cases.    N: Not reportable.    NN: Not Nationally Notifiable    Cum: Cumulative year-to-date counts.    Med: Median.    Max: Maximum. * Case counts for reporting years 2013 and 2014 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly. ��� Data for meningococcal disease, invasive caused by serogroups A, C, Y, & W-135; serogroup B; other serogroup; and unknown serogroup are available in Table I.More information on NNDSS is available at http://wwwn.cdc.gov/nndss/.
Quantification of mechanical behavior of rat tail under compression

The development of vibration-induced finger disorders is likely associated with combined static and dynamic responses of the fingers to vibration exposure. To study the mechanisms of these disorders, a new rat-tail model has been established to mimic the finger pressure and vibration exposures. However, the mechanical behavior of the tail during compression needs to be better understood to improve the model and its applications. The purpose of the current study was to investigate the static and time-dependent force responses of the rat tail during compression. Compression tests were conducted on male Sprague-Dawley cadaver rat tails using a micromechanical testing system at three deformation velocities and three deformation magnitudes. Contact-width, and the time-histories of force and deformation were measured. Additionally, force-relaxation tests were conducted and a Prony series was used to model the force-relaxation behavior of the tail.
Compound 528162: 3-Methoxy-2-phenyl-inden-1-one

Chemical compound data from PubChem database. IUPAC Name: 3-methoxy-2-phenylinden-1-one. Molecular Formula: C16H12O2. Molecular Weight: 236.26. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527824: Adipic acid, 2-amino, butyl ester, TFA

Chemical compound data from PubChem database. IUPAC Name: dibutyl 2-[(2,2,2-trifluoroacetyl)amino]hexanedioate. Molecular Formula: C16H26F3NO5. Molecular Weight: 369.38. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Worldwide trends in mortality from biliary tract malignancies

Background
          Intrahepatic cholangiocarcinomas are malignant tumors arising from the intrahepatic biliary tract. The pathogenesis of these tumors remains unknown. Although there is a marked global variation in prevalence, some recent studies have suggested an increase in mortality from intrahepatic cholangiocarcinoma in several regions of low endemicity. As the study of mortality trends may yield clues to possible etiological factors, we analyzed worldwide time trends in mortality from biliary tract malignancies.
        
        
          Methods
          Annual age-standardized rates for individual countries were compiled for deaths from biliary tract malignancies using the WHO database. These data were used to analyze gender and site-specific trends in mortality rates.
        
        
          Results
          An increasing trend for mortality from intrahepatic cholangiocarcinoma was noted in most countries. The average estimated annual percentage change (EAPC) in mortality rates for males was 6.9 ± 1.5, and for females was 5.1 ± 1.0. Increased mortality rates were observed in all geographic regions. Within Europe, increases were higher in Western Europe than in Central or Northern Europe. In contrast, mortality rates for extrahepatic biliary tract malignancies showed a decreasing trend in most countries, with an overall average EAPC of -0.3 ± 0.4 for males, but -1.3 ± 0.4 for females.
        
        
          Conclusions
          There has been a marked global increase in mortality from intrahepatic, but not extra-hepatic, biliary tract malignancies.
2013 CMHS Uniform Reporting System (URS) Table for West Virginia

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Tables for West Virginia for 2013. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program.  State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
2013 CMHS Uniform Reporting System (URS) Table for Nevada

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Tables for Nevada for 2013. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program.  State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Program Instruction (PI-20-14)

This Program Instruction (PI) provides guidance to Indian Tribes, Indian Tribal Organizations and Indian Tribal Consortia (hereafter “tribes,” unless otherwise noted) on actions they are required to take to receive their allotments for Federal Fiscal Year (FY) 2022 (subject to the availability of appropriations) authorized under title IV-B, subparts 1 and 2, and Chafee and ETV programs.

PI-20-14 (PDF)

Fiscal Year 2020 Allotment for Title IV-B, Subpart 1 Stephanie Tubbs Jones Child Welfare Services Funding
Fiscal Year 2020 Allotment for Title IV-B, Subpart 1 Disaster Relief Supplemental Funding
Fiscal Year 2020 Allotment for Title IV-B, Subpart 1 CARES Act Supplemental Funding
Fiscal Year 2020 Allotment for Title IV-B, Subpart 2 Promoting Safe and Stable Families Grants
Fiscal Year 2020 Allotment for Title IV-B, Subpart 2 Kinship Navigator Grants
Fiscal Year 2020 Allotment for Chafee Foster Care Program for Successful Transition to Adulthood Grants
Fiscal Year 2020 Allotment for Education and Training Vouchers Grants
Fiscal Year 2020 Allotment for Family First Prevention Services Act Transition Grant Funding

CFS-101 Instructions, Part I, II, and III

Introduction
Part I: Annual Budget Request for Title IV-B, Subpart 1 & 2 Funds, Chafee, and ETV Instructions
Part II: Annual Estimated Expenditure Summary of Child and Family Services Instructions
Part III: Expenditures for Title IV-B, Subparts 1 and 2, Chafee Foster Care Independence (Chafee) and Education and Training Voucher (ETV) Programs Instructions

CFS-101 Forms, Parts I, II and III Excel Workbook (XLSX)

CFS-101 Forms Part I
CFS-101 Forms Part II
CFS-101 Forms Part III

CB Regional Program Managers

Annual Reporting of Education and Training Vouchers Awarded

Certification of Tribal Population Under Age 21

See also, link to ACYF-CB-PI-19-04, Attachment H (DOCX)
Template for a Tribal Child and Family Services Plan / Annual Progress and Services Report

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 530664: 4-Butylbenzoic acid, hex-4-yn-3-yl ester

Chemical compound data from PubChem database. IUPAC Name: hex-4-yn-3-yl 4-butylbenzoate. Molecular Formula: C17H22O2. Molecular Weight: 258.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530185: 3-(4-Isopropyl-phenyl)-acrylic acid

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 2-[2,5-bis(trimethylsilyloxy)-4H-imidazol-4-yl]acetate. Molecular Formula: C14H30N2O4Si3. Molecular Weight: 374.65. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2010 CMHS Uniform Reporting System (URS) Output Tables for Virginia

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2010. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 528212: Benzoic acid, 2-hydroxy-5-methyl-3-(1,1-dimethylethyl), DTBS

Chemical compound data from PubChem database. IUPAC Name: 2,2,8-tritert-butyl-6-methyl-1,3,2-benzodioxasilin-4-one. Molecular Formula: C20H32O3Si. Molecular Weight: 348.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525391: 2,6-Dimethyl-3,5-dithiaheptane

Chemical compound data from PubChem database. IUPAC Name: 2-(propan-2-ylsulfanylmethylsulfanyl)propane. Molecular Formula: C7H16S2. Molecular Weight: 164.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Desmopressin acetate

Desmopressin Acetate is a prescription injectable solution used to treat bleeding disorders like hemophilia and certain types of diabetes insipidus by helping the body control blood clotting and water balance. It is administered intravenously or subcutaneously and comes in a 4 mcg/mL concentration from Sagent Pharmaceuticals. This information was generated using AI and is provided for informational and research purposes only.
The thermal stability of the

We have investigated the thermal stability of the Fusarium solani pisi cutinase as a function of pH, in the range from pH 2–12. Its highest enzymatic activity coincides with the pH-range at which it displays its highest thermal stability. The unfolding of the enzyme as a function of pH was investigated by microcalorimetry. The ratio between the calorimetric enthalpy (ΔHcal) and the van't Hoff enthalpy (ΔHv) obtained, is far from unity, indicating that cutinase does not exhibit a simple two state unfolding behaviour. The role of pH on the electrostatic contribution to the thermal stability was assessed using TITRA. We propose a molecular interpretation for the pH-variation in enzymatic activity.
Compound 526133: 4-Pentenoic acid, 2-propyl, trimethylsilyl ester

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 2-propylpent-4-enoate. Molecular Formula: C11H22O2Si. Molecular Weight: 214.38. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas

Background
          Intraoperative radiation therapy (IORT) is one of the methods used to deliver a large single dose to the tumor tissue while reducing the exposure of normal surrounding tissue. However, the usefulness of intraoperative electron therapy for malignant gliomas has not been established.
        
        
          Methods
          During the period from 1987 to 1997, 32 patients with malignant gliomas were treated with IORT. The histological diagnoses were anaplastic astrocytoma in 11 patients and glioblastoma in 21 patients. Therapy consisted of surgical resection and intraoperative electron therapy using a dose of 12–15 Gy (median, 15 Gy). The patients later underwent postoperative external radiation therapy (EXRT) with a median total dose of 60 Gy. Each of the 32 patients treated with IORT was randomly matched with patients who had been treated with postoperative EXRT alone (control). Patients were matched according to histological grade, age, extent of tumor removal, and tumor location.
        
        
          Results
          In the anaplastic astrocytoma group, the one-, two- and five-year survival rates were 81%, 51% and 15%, respectively in the IORT patients and 54%, 43% and 21%, respectively in the control patients. In the glioblastoma group, one-, two- and five-year survival rates were 63%, 26% and 0%, respectively in the IORT patients and 70%, 18% and 6%, respectively in the control patients. There was no significant difference between survival rates in the IORT patients and control patients in either the anaplastic astrocytoma group or glioblastoma group.
        
        
          Conclusions
          IORT dose not improve survival of patients with malignant gliomas compared to that of patients who have received EXRT alone.
Patent AT-E400879-T1: [Translated] HEADEND PROCESS FOR REPROCESSING REACTOR CORE MATERIAL

In a head-end process for the reprocessing of reactor core material with embedded fuel particles, reactor core material is arranged in a reactor containing a fluid. The reactor comprises a voltage discharge installation in the fluid. Voltage discharges are applied through the fluid for fragmenting the fuel particles into fragmentation products and the fragmentation products are segregated.